hcc

网络  原发性肝细胞肝癌; 肝细胞癌; 肝癌; 原发性肝细胞癌

医学



双语例句

  1. Objective To study the mechanism of spontaneous rupture of hepatocellular carcinoma ( HCC).
    目的:探讨肝癌自发性破裂的病理机制。
  2. Objective: To investigate the expression and clinical significance of IL-17 in primary human hepatocellular carcinoma ( HCC).
    目的:探讨IL-17在原发性肝癌组织中的表达及其临床意义。
  3. We show a novel mechanism of HCC development by LSF that provides us with fresh insight into the complex etiology and mechanism of carcinogenesis process.
    我们通过LSF显示了肝癌的进展的新机制,为我们研究肿瘤进程机制和复杂病因提供了新的见解。
  4. Objective To explore the genetic mechanisms underlying the metastatic phenotype of hepatocellular carcinoma ( HCC).
    目的探索肝癌转移的分子细胞遗传学机制。
  5. There is strong evidence demonstrating the association of chronic HCV infection to cirrhosis and hepatocellular carcinoma ( HCC).
    众多资料表明,慢性HCV感染与肝硬化和肝细胞癌相关。
  6. The Cleveland Clinic study established that NASH-induced cirrhosis is a much greater risk factor for HCC than previously thought.
    克利夫兰临床部的研究明确了NASH相关性肝硬化,是进展为HCC的一个很重要的危险因素,强于以前我们对其的认识。
  7. HBV infection is a known cause of hepatocellular carcinoma ( HCC), the most common form of liver cancer.
    HBV感染是已知导致肝细胞癌(HCC)&一种最常见的肝癌类型的原因之一。
  8. Patients were matched for factors associated with HCC recurrence and survival.
    依据与HCC复发和生存有关的因素对病人进行筛选。
  9. Cryosurgery is an important treatment modality for unresectable hepatocellular carcinoma ( HCC).
    冷冻疗法已成为治疗不能手术切除肝癌的重要手段。
  10. Heterogeneity in reporting means that these data may underestimate the rate of disease progression, particularly HCC development.
    研究的异质性表明,这些数据可能低估疾病的进展速度,尤其是HCC的发生。
  11. Conclusion: The selection of different interventional treatments should be done according to the size and type of HCC.
    结论肝癌的介入治疗应根据肿瘤大小和类型选择不同的介入治疗方式;
  12. Mechanism of HCC development induced by DNA damage and repair and integration of HBV
    DNA损伤与修复、HBV整合和HCC发病机制的研究进展
  13. Conclusion: LOH of DCC gene may be involved in the occurrence and development of HCC.
    结论:DCC基因LOH可能参与了原发肝癌的发生发展。
  14. Regular screening for HCC is necessary for NASH patients, especially the elderly men with multiple metabolic disorders.
    有必要对合并多元代谢紊乱的NASH患者,尤其是男性和年老患者进行定期HCC筛检。
  15. Treatment options for HCC include chemotherapy, chemoembolization, ablation and proton-beam therapy.
    肝癌的治疗选择包括化疗、栓塞、消融和质子束疗法。
  16. HCC is generally hypervascular, and vascular endothelial growth factor ( VEGF) promotes HCC development and metastasis.
    肝癌通常血供丰富,血管内皮生长因子促进其生长和转移。
  17. Analysis of LSF level in biopsy material may one day be used as a prognostic marker for HCC.
    对活检标本LSF水平的分析,有朝一日可以被用来作为肝癌的预后指标。
  18. Conclusion Primary resistance existed in HCC and there were many mechanisms of multidrug resistance.
    结论肝细胞癌中存在有原发性耐药的现象,且多种机制并存。
  19. The team is currently testing small molecule inhibitors of LSF as a possible therapy for HCC in animal models.
    该小组目前正在肝癌动物模型中验证LSF的小分子抑制剂,作为可能的治疗方法。
  20. Although these patients receive systemic treatment including chemotherapy, HCC is generally recognized as a chemo-resistant tumor.
    虽然这些病人得到了包括化疗在内的系统化治疗,肝癌通常被认为是化疗抵抗性肿瘤。
  21. HCV infection can lead to chronic hepatitis, cirrhosis, and hepatocellular carcinoma ( HCC) or primary liver cancer.
    丙肝病毒可以导致慢性肝炎,肝硬化,肝细胞肝癌或原发性肝癌。
  22. HCC is a primary cancer of the liver.
    肝细胞癌是肝脏的原发性癌症。
  23. There is no established molecular classification of HCC, although preliminary proposals have already been published.
    尽管初步的提议已经公布,但是至今肝细胞癌仍然没有一个确定的分子分类。
  24. To establish hepatocellular carcinoma cell lines and provide more pure liver carcinoma cells for HCC studies.
    张萌,胡少为,姜桔红,文剑明建立新的肝细胞癌细胞系,为肝癌实验研究提供更多纯化癌细胞。
  25. Antiangiogenesis is a kind of hopeful strategy for the prevention of relapse and metastasis of HCC.
    抗血管生成是预防和治疗HCC复发转移的重要策略之一。
  26. The aim of this review is to provide an up-to-date summary of recent advances in the field of HCC.
    这篇综述的目的是为肝癌研究领域的最新进展做个最新的总结。
  27. Objective To investigate the risk factors associated with HCC arising in CC ( cryptogenic cirrhosis).
    目的研究在隐源性肝硬化基础上发生肝癌的危险因素。
  28. In the Cox proportional hazards model, waitlist time was also not a significant predictor of HCC recurrence.
    在Cox比例危险率模型中,等待时间也不是肝细胞癌复发的显著预测因子。
  29. Objective: To investigate the predictive factors of blood transfusion in liver resection for hepatocellular carcinoma ( HCC).
    目的:探讨肝癌肝切除输血的预测因素。
  30. Objective: To establish a reasonable protocol for interventional treatment of hepatocellular carcinoma ( HCC).
    目的探讨肝癌介入治疗的合理模式。